ENTITY
Ascletis Pharma Inc

Ascletis Pharma Inc (1672 HK)

81
Analysis
Health CareChina
Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.
more
bearishTencent Music
17 Dec 2018 09:01

Last Week’s GER IPO Research: Tencent Music, IPO Trading Strategy Deep Dive, WuXi, Junshi & Xinyi

Another busy week for IPO research from the GER team. This week, we recap the Tencent Music Entertainment (TME US) IPO which we noted is more...

Logo
570 Views
Share
bullishTencent Music
08 Dec 2018 18:42

Last Week's GER IPO Research: Tencent Music, Softbank, Weimob, Luzhou, Junshi, Yancoal and Asiainfo

We had another busy week for IPO research the GER team. This week, we recommend participating in the Tencent Music Entertainment (TME US) IPO,...

Logo
624 Views
Share
bearishWuXi AppTec
03 Dec 2018 08:47

Last Week in GER IPO Research: Wuxi, Mobvista, Yancoal, IDreamSky, Mogu, Asiainfo, Softbank & More!

Last week was a busy week for IPO content. In this edition, we highlight a differentiated AH premium piece on pharma outsourcer WuXi AppTec Co....

Logo
479 Views
Share
bearishWuXi AppTec
26 Nov 2018 05:52

Last Week in GER Research: WuXi App, Don Quijote, Koolearn, Asiainfo and China's Bike Sharing Bubble

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we update on IPO WuXi AppTec Co....

Logo
508 Views
Share
bullishWuXi AppTec
21 Nov 2018 10:41

Wuxi Apptec 药明康德 IPO: Welcome to the A/H Universe

WuXi Apptec is set to be the newest A/H pair with its upcoming HK listing that is set to raise USD 1 billion. The A-share (603289 CH) recorded 15...

Share
x